Audere is closing gaps in HIV care and education with the help of Amy, their artificial intelligence companion designed to reach women and young girls in South Africa, according to Sarah Morris, CPO of Audere.
Women and young girls in Africa are disproportionately at risk for HIV, due to education barriers, stigma and gender-based violence. Specifically, of all new HIV infections occurring among adolescents in sub-Saharan Africa, 80% are in girls aged 15–19 years old. In 2017, HIV cases in women and children ages 10 to 19 living in Eastern and Southern Africa accounted for 25% of HIV infections globally, according to an article published in The Lancet Global Health.
Nonprofit company, Audere, is using generative AI (GenAI) to lessen incidence and promote HIV prevention in South Africa.
Their program, called Self-Care from Anywhere, provides youth-focused prevention engagement via WhatsApp. Care is delivered through a confidential AI companion called Amy.
“Amy helps people navigate that self-care journey,” Sarah Morris, CPO of Audere, said during a recent interview with Managed Healthcare Executive. “She provides them personalized counseling. She remembers what they shared last time she asked them about their life and what she's doing is collecting information to understand their vulnerability, guiding them towards HIV self-testing.”
Sarah Morris
The platform is tied to a telehealth center run by clinicians, who can then provide the services users seek.
Morris and her colleagues recently presented at the International AIDS Society meeting in Kigali, Rwanda.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
June 19th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More
Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks
June 10th 2025Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C.
Read More